Curative treatment of autosomal-recessive hyper-IgE syndrome by hematopoietic cell transplantation

Bone Marrow Transplantation
S A GatzW Friedrich

Abstract

Autosomal-recessive hyper-IgE syndrome (AR-HIES) is a combined immunodeficiency recently found to be associated with mutations of DOCK8. Clinically, this disorder is characterized beside recurrent bacterial complications, in particular by an unusual susceptibility to extensive cutaneous viral complications and by a high risk for squamous cell carcinoma. Here, we report on lasting control over the disorder in two patients by hematopoietic cell transplantation (HCT). Both patients were suffering from extensive long-lasting cutaneous viral complications, in particular from disfiguring molluscum contagiosum infections, when treated at the age of 10 and 17 years. Donors were matched unrelated, and conditioning was carried out with a combination of fludarabine, melphalan and BM-targeted radioimmunotherapy. Both patients developed stable, full donor cell chimerism, with the exception of persistent low-IgA serum levels and the exception of normal immune functions. Over the course of several months, cutaneous manifestations of viral disease resolved completely and both patients remain clinically well and free of infectious complications at 4 and 2 years, respectively, after transplantation. This represents the first report indicating HC...Continue Reading

References

Jan 15, 2004·The Journal of Pediatrics·Eleonore D RennerBodo Grimbacher
Sep 21, 2007·The New England Journal of Medicine·Steven M HollandBodo Grimbacher
Apr 22, 2008·Immunology and Allergy Clinics of North America·Alexandra F Freeman, Steven M Holland
Sep 25, 2009·The New England Journal of Medicine·Qian ZhangHelen C Su
Dec 17, 2009·The Journal of Allergy and Clinical Immunology·Karin R EngelhardtTalal A Chatila

❮ Previous
Next ❯

Citations

Apr 6, 2012·Journal of Clinical Immunology·Ozden SanalHelen C Su
Sep 25, 2010·Current Opinion in Allergy and Clinical Immunology·Helen C Su
Oct 6, 2011·Current Opinion in Pediatrics·Qian Zhang, Helen C Su
Nov 17, 2011·Orphanet Journal of Rare Diseases·Aleksandra Szczawinska-PoplonykKarolina Gerreth
Dec 6, 2012·Arthritis Research & Therapy·Patrick F K YongBodo Grimbacher
Jan 10, 2013·Annual Review of Immunology·Luigi D Notarangelo
Mar 13, 2014·Journal of Clinical Immunology·John RoutesTroy Torgerson
Oct 19, 2011·The Journal of Experimental Medicine·Katrina L RandallChristopher C Goodnow
May 15, 2015·International Reviews of Immunology·Trine H Mogensen
Feb 22, 2016·Infectious Disease Clinics of North America·Xiaowen WangMihai G Netea
Mar 8, 2013·The Journal of Allergy and Clinical Immunology·Luigi D Notarangelo
Apr 26, 2011·The Journal of Allergy and Clinical Immunology·Nima RezaeiKim E Nichols
Jun 11, 2015·Case Reports in Immunology·Soheyla AlyasinMohammad Bahadoram
Sep 16, 2015·The Journal of Allergy and Clinical Immunology·Francisco A BonillaJames W Verbsky
Jan 13, 2012·Annals of the New York Academy of Sciences·Helen C SuQian Zhang
Jul 19, 2013·European Journal of Haematology·Beáta TóthLászló Maródi
Dec 2, 2011·Annals of the New York Academy of Sciences·Mary A Slatter, Andrew J Cant
Oct 15, 2013·Immunological Reviews·Dale A MouldingAdrian J Thrasher
Feb 1, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Jennifer Cuellar-RodriguezDennis D Hickstein
May 7, 2014·The Journal of Allergy and Clinical Immunology·Huie JingHelen C Su
Aug 19, 2015·Journal of the American Academy of Dermatology·Dominique C PichardEdward W Cowen
Apr 20, 2014·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Daifulah Al-ZahraniRaif Geha
Mar 1, 2015·The Journal of Allergy and Clinical Immunology·Karin R EngelhardtBodo Grimbacher
Jul 27, 2015·Immunology and Allergy Clinics of North America·Kelli W WilliamsAlexandra F Freeman
Jan 21, 2014·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Erin JanssenRaif S Geha
Mar 29, 2014·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Sujal GhoshRoland Meisel
Oct 6, 2012·The Journal of Allergy and Clinical Immunology·Jennifer W Leiding, Steven M Holland
Jan 29, 2013·The Journal of Allergy and Clinical Immunology·Hamoud Al-MousaZobaida Alsum
Jan 30, 2015·Journal of Clinical Immunology·Susanne E AydinUNKNOWN inborn errors working party of EBMT
May 1, 2016·The Journal of Allergy and Clinical Immunology·Waleed Al-HerzSung-Yun Pai
May 22, 2016·Journal of Clinical Immunology·Qian ZhangHelen C Su
Aug 25, 2016·The Journal of Allergy and Clinical Immunology·Stuart G TangyeCindy S Ma
Jun 20, 2017·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Catherine M BiggsTalal A Chatila
Jul 1, 2017·Pediatric Transplantation·Dilara Fatma K UygunAkif Yeşilipek
Jun 20, 2017·Pediatric Blood & Cancer·Barış KuşkonmazDuygu Uçkan
Feb 29, 2020·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Sule HaskologluAydan Ikinciogullari
Oct 10, 2013·Current Opinion in Hematology·Austen J J WorthPaul Veys
Jan 18, 2012·Pediatric Transplantation·Ayse MetinDuygu Uckan
Nov 22, 2019·Frontiers in Pediatrics·Michael H Albert, Alexandra F Freeman
Dec 20, 2018·Immunological Reviews·Helen C SuAlexandra F Freeman
Oct 4, 2018·Allergologia et immunopathologia·S AlyasinR Amin
Jan 4, 2013·The World Allergy Organization Journal·Efren L RaelJonathan J McClain

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.